摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-5-溴苯酚 | 38191-34-3

中文名称
2-氨基-5-溴苯酚
中文别名
——
英文名称
2-amino-5-bromophenol
英文别名
5-bromo-2-aminophenol;4-bromo-2-hydroxyaniline
2-氨基-5-溴苯酚化学式
CAS
38191-34-3
化学式
C6H6BrNO
mdl
——
分子量
188.024
InChiKey
DRQWUAAWZFIVTF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    146-147 °C
  • 沸点:
    265.0±25.0 °C(Predicted)
  • 密度:
    1.768±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    46.2
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2922299090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H332,H335
  • 储存条件:
    2-8°C

SDS

SDS:9f661fc25143821dffe53c47f12739ff
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Amino-5-bromophenol
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-5-bromophenol
CAS number: 38191-34-3

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H6BrNO
Molecular weight: 188

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

2-氨基-5-溴苯酚主要用于有机合成和医药中间体。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氨基-5-溴苯酚硼酸caesium carbonate 作用下, 以 四氢呋喃乙腈 为溶剂, 反应 17.0h, 生成 7-溴-3,4-二氢-2H-1,4-苯并恶嗪
    参考文献:
    名称:
    TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
    摘要:
    化合物(I)及其光学异构体和药学上可接受的盐,以及该化合物作为FXIa抑制剂的应用。
    公开号:
    EP3998263A1
  • 作为产物:
    描述:
    间溴苯酚sodium nitrate硫酸 、 tin(ll) chloride 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 10.0h, 生成 2-氨基-5-溴苯酚
    参考文献:
    名称:
    用于有机白光发光二极管和固态照明的高效Tris(8-羟基喹啉)铝(Alq3)配合物
    摘要:
    三(8-羟基喹啉)铝(Alq 3)配合物的8-羟基喹啉配体上的吸电子和供电子取代基的组合可控制HOMO和LUMO能量以及负责从该配合物中发射的HOMO-LUMO间隙。在这里,我们提出了一个系统的研究,以调节Alq 3配合物从绿色到蓝色区域的发射和电致发光(EL)。在这项研究中,我们探索了C4和C6上给电子取代基的组合。化合物1 - 6显示0.15和0.57之间478和526纳米,和荧光量子产率之间的发射调谐。化合物2 – 6用作有机发光二极管(OLED)的发射器和主体。观察到的最高OLED外部量子效率(EQE)为4.6%,在Alq 3配合物中观察到的最高。另外,化合物3 - 5被用作红色磷光掺杂剂,以获得白色发光二极管(WOLED)的主机。WOLED显示出高效率(EQE高达19%)和高白色纯度(显色指数(CRI≈85)。
    DOI:
    10.1002/chem.201100707
点击查看最新优质反应信息

文献信息

  • Synthesis and in vitro antimycobacterial and isocitrate lyase inhibition properties of novel 2-methoxy-2′-hydroxybenzanilides, their thioxo analogues and benzoxazoles
    作者:Ján Kozic、Eva Novotná、Marie Volková、Jiřina Stolaříková、František Trejtnar、Vladimír Wsól、Jarmila Vinšová
    DOI:10.1016/j.ejmech.2012.08.016
    日期:2012.10
    Mycobacterium avium 330/88, Mycobacterium kansasii 235/80, clinically isolated M. kansasii 6509/96 and the ability to act as in vitro isocitrate lyase inhibitors. The best ICL inhibitors were two compounds from the thiobenzanilide group (8f, 8m), which exhibited an inhibition potential that was equal to the standard compound, 3-nitropropionic acid. In addition, the best antimycobacterial properties were
    合成了一系列新的2-甲氧基-2'-羟基苯甲腈衍生物及其硫代类似物,并通过红外,核磁共振和元素分析对其进行了表征。这些化合物进行了调查其体外抗分支杆菌活性针对结核分枝杆菌331 / 88,鸟分枝杆菌330 / 88,堪萨斯分枝杆菌235 / 80,临床分离堪萨斯分枝6509 / 96和充当能力体外异柠檬酸裂解酶抑制剂。最好的ICL抑制剂是硫代苯甲腈类的两种化合物(8f,8m),其显示出与标准化合物3-硝基丙酸相同的抑制潜能。另外,具有5-Cl和4'或5'Cl / Br取代的苯甲酰苯胺衍生物6h,6k和6l表现出最佳的抗分枝杆菌性能。对于所有测试的硫代苯甲腈衍生物,在NMR谱图中观察到两个构象异构体,这很可能是由于C–N键的旋转受阻所致。
  • IRAK DEGRADERS AND USES THEREOF
    申请人:Kymera Therapeutics, Inc.
    公开号:US20190192668A1
    公开(公告)日:2019-06-27
    The present invention provides compounds, compositions thereof, and methods of using the same.
    本发明提供了化合物、其组合物以及使用这些化合物的方法。
  • [EN] COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 1 PROTEINS<br/>[FR] COMPOSÉS ET PROCÉDÉS POUR LA DÉGRADATION CIBLÉE DE PROTÉINES DE KINASE 1 ASSOCIÉS AU RÉCEPTEUR DE L'INTERLEUKINE 1
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2021018118A1
    公开(公告)日:2021-02-04
    The present invention relates to compounds comprising an interleukin-1 receptor-associated kinase 1 (IRAK1) protein binding moiety and a Von Hippel-Lindau (VHL) E3 ubiquitin ligase binding moiety, and associated methods of use. The compounds are useful as modulators of targeted ubiquitination, especially with respect to IRAK1, which is degraded by the compounds according to the invention.
    本发明涉及包含白细胞介素-1受体相关激酶1(IRAK1)蛋白结合基团和Von Hippel-Lindau(VHL)E3泛素连接酶结合基团的化合物,以及相关的使用方法。这些化合物可用作靶向泛素化的调节剂,特别是在与根据本发明降解的IRAK1相关的情况下。
  • PROTEIN KINASE INHIBITORS
    申请人:Sheppard S. George
    公开号:US20070203143A1
    公开(公告)日:2007-08-30
    Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
    抑制蛋白激酶的化合物、含有这些化合物的组合物以及利用这些化合物治疗疾病的方法被披露。
  • BENZOXAZINE DERIVATIVES AS CRAC MODULATORS
    申请人:Hoffmann-La Roche Inc.
    公开号:US20130090333A1
    公开(公告)日:2013-04-11
    Compounds of the formula (I): or pharmaceutically acceptable salts thereof, wherein R 1 and R 2 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with calcium release-activated calcium channels (CRAC).
    公式(I)的化合物: 或其药用可接受的盐,其中R1和R2如本文所述定义。还公开了制造这些化合物的方法以及使用这些化合物治疗与钙释放激活钙通道(CRAC)相关疾病的用途。
查看更多